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Abstract
Aims/hypothesis In humans, disruption of the gene BSCL2 ,
encoding the protein seipin, causes congenital generalised
lipodystrophy (CGL) with severe insulin resistance and
dyslipidaemia. While the causative gene has been known for
over a decade, the molecular functions of seipin are only now
being uncovered. Most pathogenic mutations in BSCL2 rep-
resent substantial disruptions including significant deletions
and frameshifts. However, several more subtle mutations have
been reported that cause premature stop codons or single
amino acid substitutions. Here we have examined these mu-
tant forms of seipin to gain insight into how they may cause
CGL.
Methods We generated constructs expressing mutant seipin
proteins and determined their expression and localisation. We
also assessed their capacity to recruit the key adipogenic
phosphatidic acid phosphatase lipin 1, a recently identified
molecular role of seipin in developing adipocytes. Finally, we
used atomic force microscopy to define the oligomeric
structure of seipin and to determine whether this is affected
by the mutations.
Results We show that the R275X mutant of seipin is not
expressed in pre-adipocytes. While the other premature stop
mutant forms fail to bind lipin 1 appropriately, the point
mutants T78A, L91P and A212P all retain this capacity. We
demonstrate that wild-type human seipin forms oligomers of
12 subunits in a circular configuration but that the L91P and
A212P mutants of seipin do not.
Conclusions/interpretation Our study represents the most
comprehensive analysis so far of mutants of seipin causing
lipodystrophy and reveals several different molecular mecha-
nisms by which these mutations may cause disease.
Keywords Adipogenesis . Adipose tissue . BSCL2 . Lipin .
Lipodystrophy . Seipin
Abbreviations
AFM Atomic force microscopy
BSCL Berardinelli–Seip congenital lipodystrophy
CGL Congenital generalised lipodystrophy
ER Endoplasmic reticulum
HA Haemagglutinin
LD Lipid droplet
PA Phosphatidic acid
PPAR Peroxisome proliferator-activated receptor
Introduction
Mutations in the gene BSCL2 cause Berardinelli–Seip con-
genital lipodystrophy type 2 (BSCL2), the most severe form
of lipodystrophy. Affected individuals almost completely lack
adipose tissue [1, 2] and typically suffer from severe insulin
resistance, dyslipidaemia, hypertriglyceridaemia and muscu-
lar hypertrophy [2–4]. BSCL2 encodes the protein seipin,
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which can be either 398 or 462 amino acids long as a result of
an alternative start codon that leads to the addition of a 64
amino acid extension to the N-terminus, thereby generating
the longer form. The seipin protein has two transmembrane
domains and resides in the endoplasmic reticulum (ER) mem-
brane, with both termini in the cytoplasm [5, 6].
Studies in yeast and non-adipose cells have suggested that
seipin may affect lipid droplet (LD) size, morphology and
inheritance, although the molecular mechanism underlying
these phenomena remains unclear. Yeast cells lacking fld1p
(fldΔ1), the orthologue of seipin, form irregular LDs with
proliferation of the ER and impaired lipolysis [7–11]. The
fldΔ1 cells also show alterations in phospholipid composition
and in levels of phosphatidic acid (PA) [8, 9]. Failure to
identify any seipin-interacting proteins in yeast has led to
speculation about a structural role for seipin in the budding
of LDs from the ER membrane [7].
Seipin has been shown to play an essential cell-autonomous
role in adipogenesis [12, 13]. A lack of seipin causes failure to
sustain the expression of key adipogenic factors, including
peroxisome proliferator-activated receptor γ (PPARγ), which
may explain the significantly reduced expression of adipogenic
genes [12, 13]. Mouse embryonic fibroblasts lacking seipin
undergo unrestrained lipolysis at a relatively early stage of
adipogenesis, causing the loss of lipid initially stored in
these cells and loss of adipogenic gene expression [14].
This observation provided the first indications as to how
the lack of seipin may contribute to failure of adipogenesis;
however, the molecular details of this phenomenon remain
uncertain. Recently, we demonstrated that seipin can bind
the PA phosphatase lipin 1, which itself is required for
adipogenesis and adipose tissue development in mice
[15–18]. Seipin knockdown increases levels of the lipin 1
substrate PA and decreases the association of lipin 1 with the
ER membrane in differentiating adipocytes [17]. Lipin 1
binding requires the C-terminal cytoplasmic domain of seipin
[17], which Yang and colleagues have shown is critical for the
adipogenic function of the protein [19]. In contrast, the LD
modifying function of seipin appears to be mediated by a
conserved core seipin sequence present in the yeast
orthologue, which lacks this cytoplasmic domain [8, 10, 19].
Previously published studies regarding mutations in seipin
that cause congenital generalised lipodystrophy (CGL) have
focused mainly on the A212P mutant form of seipin [13, 20].
Here, we perform a more comprehensive analysis of the
effects of several mutations in seipin that cause lipodystrophy.
We have examined four point mutations that result in prema-
ture truncation of the seipin protein when translated (E113X,
R138X, R275X, Q391X) and three point mutations that cause
single amino acid substitutions (T78A, L91P, A212P) [2, 3,
21]. Our data indicate that several pathogenic mechanisms
may underlie the failure of adipocyte development in BSCL2
patients carrying these mutations.
Methods
Constructs Constructs to express haemagglutinin (HA)-
tagged lipin 1β, Myc- and FLAG-tagged long forms of seipin
were as previously described [5, 13, 17, 22]. All Myc- and
FLAG-tagged seipin mutants were generated from wild-type
constructs using the QuikChange II Site-Directed Mutagene-
sis kit (Agilent Technologies, Wokingham, UK) and appro-
priate changes were confirmed by sequencing.
Cell culture Human HEK293 and murine C3H10T1/2 cells
were routinely cultured, and C3H10T1/2 cells were differen-
tiated, as previously described [13, 17]. Confluent C3H10T1/
2 cells were transiently transfected using Lipofectamine LTX
(Invitrogen, Paisley, UK) and immediately induced to differ-
entiate. Cells were lysed 48 h later. HEK293 cells were
cultured in DMEM (Sigma, Dorset, UK) containing 10%
(vol./vol.) FBS and transiently transfected using Fugene6
Transfection Reagent (Promega, Southampton, UK). HEK293
cells were harvested 48 h after transfection. For atomic force
microscopy (AFM) experiments tsA 201 cells, a sub-clone of
HEK293 cells stably expressing the SV40 large Tantigen, were
grown in DMEM supplemented with 10% (vol./vol.) FBS,
100 U/ml penicillin and 100 μg/ml streptomycin in an atmo-
sphere of 5% CO2/air. Transfection was carried out using
calcium phosphate precipitation. A total of 250 μg of DNA
was used to transfect cells in 5×162 cm2 culture flasks and cells
were harvested 48 h later.
Immunoprecipitations and immunoblotting Cells were lysed
in 50 mmol/l Tris, pH 7.4, 150 mmol/l NaCl, 1 mmol/l EDTA
containing 50 mmol/l n-octyl-β-D-glucopyranoside and pro-
tease inhibitors (Complete EDTA free; Roche, Burgess Hill,
UK). Samples were sonicated, and centrifuged at 16,000g for
10 min at 4°C. Supernatant fractions containing 1 mg of
protein were incubated with anti-FLAG antibody conjugated
to agarose beads (Santa Cruz, Dallas, TX, USA) for 2 h at 4°C.
Immunoprecipitated samples were eluted using triple-FLAG
peptide (Sigma). Samples were separated by SDS-PAGE, and
immunoblotted using antibodies to Myc (clone 4A6;
Millipore, Watford, UK), FLAG (Sigma), HA (Y-11, Santa
Cruz), lipin 1 (generously provided by Symeon Siniossoglou,
CIMR, Cambridge, UK) or calnexin (Abcam, Cambridge,
UK). Following incubation with horseradish peroxidase-
linked secondary antibodies, bands were visualised by en-
hanced chemi-luminescence (ECL). All immunoblots are rep-
resentative of at least three independent experiments. Blots
were quantified using ImageJ 1.45 s (http://imagej.nih.gov/ij).
Immunofluorescence Cells were grown and transfected on
glass coverslips and then fixed, permeabilised, blocked and
probed with antibodies as previously described [17, 23]. An-
tibodies used were as described for immunoblotting. Highly
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cross-adsorbed Alexa Fluor anti-mouse 488 or anti-rabbit 594
secondary antibodies were used for detection (Invitrogen).
Coverslips were mounted with Prolong Gold antifade reagent
with DAPI (Invitrogen) and analysed on a Carl Zeiss LSM510
META Confocal microscope (Carl Zeiss, Cambridge, UK).
Fluorescence from 405 nm excitation of DAPI was collected
through a 420–480 nm bandpass filter; 488 nm excitation
emission was collected through a 505–575 nm bandpass filter,
and emission from 594 nm through a long-pass 615 nm filter.
Images were recorded and analysed using Zeiss ZEN software
with a 63x objective.
RNA extraction and real-time quantitative PCR Total RNA
was extracted using RNeasy kits (Qiagen, Hilden, Germany),
following the manufacturer’s instructions. cDNA was
synthesised, and real-time PCR was performed with Taqman
or Sybr Green reagents (ABI, Paisley, UK) as previously
described [23].
AFM imaging Wild-type and mutant seipin constructs were
expressed in tsA 201 cells. Transfected cells were solubilised
in 1% Triton X-100 for 1 h, centrifuged at 61,740g to remove
insoluble material and then incubated with anti-FLAG-agarose
beads for 3 h. Proteins were eluted with triple-FLAG peptide
(0.15 mg/ml). All purification steps were carried out at 4°C.
Isolated proteins were imaged either alone or following
overnight incubation with anti-Myc, anti-HA or anti-V5 anti-
bodies. Various dilutions of each protein sample were made,
and 45 μl of each sample was allowed to adsorb onto freshly
cleaved mica disks. After a 5 min incubation, the sample was
washed with Biotechnology Performance Certified-grade wa-
ter (Sigma) and dried in a stream of nitrogen gas. Imaging was
performed with a Veeco Digital Instruments Multimode atom-
ic force microscope controlled by a Nanoscope IIIa controller
(Veeco, Cambridge, UK). Samples were imaged in air, using
tapping mode. The silicon cantilevers used had a drive fre-
quency of∼300 kHz and a specified spring constant of 40N/m
(Olympus, Southend, UK). The applied imaging force was
kept as low as possible (AS/A0 ∼0.85). Disks with approxi-
mately equal protein densities for the various constructs were
chosen for subsequent analysis.
The molecular volumes of protein particles were deter-
mined from particle dimensions based on AFM images. After
adsorption of the proteins onto the mica support, the particles
adopted the shape of a spherical cap. Molecular volume was
calculated using the equation
Vm ¼ πh=6ð Þ 3r2 þ h2
  ð1Þ
where h is the particle height and r is the radius. Molecular
volume based on molecular mass was calculated using the
equation
V c ¼ M 0=N 0ð Þ V 1 þ dV 2ð Þ ð2Þ
where M0 is the molecular mass, N0 is Avogadro’s number,
V 1 and V 2 are the partial specific volumes of particle
(0.74 cm3/g) and water (1 cm3/g), respectively, and d is the
extent of protein hydration (taken as 0.4 g water/g protein). It
has been shown previously [24] that the molecular volumes of
proteins measured by imaging in air are similar to the values
obtained by imaging under fluid; hence, the process of drying
does not significantly affect the measured molecular volume.
It has also been shown by us [25] and by others [24] that there
is a close correspondence between the measured and predicted
molecular volumes for various proteins over a wide range of
molecular masses; hence, molecular volume is measured rea-
sonably accurately by AFM imaging.
Data were separated into appropriate bin widths and histo-
grams plotted. Gaussian curves were fitted and the mean value
of the peaks calculated.
Results
The R275X mutation in seipin, but not other premature stop
mutations, leads to a lack of protein expression in pre-
adipocytes To examine how premature stop mutations may
affect the function of seipin, we generated constructs in which
the E113X, R138X, R275X and Q391X pathogenic mutations
[2, 3, 21] were introduced by site-directed mutagenesis into
the full-length cDNA encoding the long form of seipin bear-
ing an N-terminal triple-FLAG tag and a C-terminal Myc tag.
These constructs were transfected into HEK293 cells to ensure
maximal transfection efficiency and protein abundance and
each resulted in the expression of proteins of the expected
sizes when probed with antibodies to detect the triple-FLAG
tag at their N-termini (Fig. 1a). As predicted, only wild-type
seipin resulted in the expression of a protein that could be
detected via the C-terminal Myc tag, confirming that each
pathogenic mutation caused the expected premature stop in
translation.
To examine expression in a more relevant pre-adipocyte
cell line the above constructs were expressed in C3H10T1/2
cells. Consistent with our previous studies using an artificially
truncated version of the short form of human seipin [13], we
were unable to detect the R275X mutant seipin protein
(Fig. 1b). However, the other three premature stop seipin
mutants tested were robustly expressed. Quantified data are
shown in Fig. 1c. We observed a doublet for E113X when
expressed in C3H10T1/2 cells and suspect that the lower band
represents the monomer and the upper a partially denatured
form of the protein as the samples were not heated before
separation on SDS-PAGE. Real-time PCR analysis revealed
equivalent expression of mRNA encoding wild-type or
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mutant forms of seipin, confirming that the inability to detect
the R275X seipin did not result from altered levels of mRNA
expression (Fig. 1d). Despite the high sequence similarity
between murine and human seipin we observed no signal in
mock-transfected cells (m, Fig. 1d), demonstrating that this
assay did not detect endogenous murine Bscl2 mRNA.
When analysed by confocal microscopy, wild-type seipin
showed the typical reticular distribution and co-localisation
with calnexin, consistent with the previously reported ER
localisation (Fig. 1e) [5, 13, 20]. Although very few cells
transfected with the R275X mutant seipin showed any stain-
ing for the protein, in occasional cells showing weak expres-
sion the R275X seipin co-localised with the ER marker
calnexin, as did the other premature stop mutants examined.
The T78A, L91P and A212P mutations do not dramatically
affect seipin protein expression, but L91P and A212P seipin
show altered localisation We next examined the effect of the
T78A, L91P and A212P mutations on seipin expression.
When each of these constructs was transfected into either
HEK293 cells (Fig. 2a) or C3H10T1/2 cells (Fig. 2b), seipin
was robustly expressed. However, we observed that the L91P
and A212P mutations did result in a modest reduction in
protein expression when compared with wild-type or T78A
seipin (Fig. 2c). This was not the result of a significant effect
of these mutations on mRNA expression levels (Fig. 2d).
We and others have previously observed that A212P seipin
can display an altered localisation, giving a characteristic ring
of fluorescence around the nucleus [13, 20]. As shown in
Fig. 2e, we again observed this partial mislocalisation of
A212P seipin. A similar effect was observed with L91P
seipin. This partial redistribution of L91P and A212P seipin
was observed in all cells expressing these constructs whether
subconfluent pre-adipocytes (Fig. 2e) or post-confluent cells
induced to differentiate for 48 h (electronic supplementary
material [ESM] Fig. 1). In contrast, the subcellular distribution
of T78A seipin appeared to be identical to that of wild-type
seipin.
The T78A, L91P and A212P mutations do not affect the
capacity of seipin to bind lipin 1 We have recently demon-
strated that seipin can bind to the PA phosphatase lipin 1,
including endogenous lipin 1 in differentiating cultured adi-
pocytes. This interaction appears to be important for appro-
priately targeting this pro-adipogenic enzyme to the ER in
differentiating pre-adipocytes [17]. We also showed that the
premature stopmutants of seipin, E113X, R138X and R275X,
appeared unable to bind lipin 1. In addition, the ability of Q391X
seipin to bind lipin 1 is significantly reduced [17]. Similar data
are shown in ESM Fig. 2. We therefore asked whether the point
mutations T78A, L91P and A212P influence lipin 1 binding to
seipin. As shown in Fig. 3a, b, we observed no decrease in the
ability of seipin to co-immunoprecipitate lipin 1 (quantified data
are shown in Fig. 3b). Hence, while the failure to target lipin 1
appropriately offers a potential pathogenic mechanism for the
premature stop mutants of seipin, it appears unlikely to explain
Fig. 1 The R275X mutation in seipin leads to loss of protein expression
in differentiating adipocyte precursors. (a ) HEK293 cells were
transfected with empty vector (−), the long form of wild-type seipin
bearing N-terminal triple-FLAG and C-terminal Myc tags (WT) or iden-
tically tagged forms with the point mutations E113X, R138X, R275X or
Q391X. Lysates were separated by SDS-PAGE and immunoblotted for
FLAG (α-FLAG), Myc (α-Myc) and calnexin (α-Calnexin). (b) Conflu-
ent C3H10T1/2 cells were transfected with empty vector (−) or with
epitope-tagged WT or mutant forms of seipin as in (a). Cells were
induced to differentiate for 2 days; lysates were separated by SDS-PAGE
and immunoblotted for FLAG,Myc and calnexin. In (a) and (b) blots are
representative of at least three independent experiments. (c) Quantitative
analysis of WT, E113X, R138X, R275X or Q391X forms of seipin
protein in C3H10T1/2 cells. FLAG–seipin bands from replicated blots
as shown in (b) were normalised to calnexin expression in the same
samples and expressed as means ± SEM, n =3. *p <0.05 vs WT. (d)
C3H10T1/2 cells were transfected with empty vector (m) or with epitope-
tagged WT or mutant forms of seipin as in (a). Cells were induced to
differentiate for 2 days, and expression of mRNA encoding transfected
human seipin (hBSCL2 mRNA) was determined by real-time PCR. Data
are normalised to cyclophilin A and expressed as means ± SEM, n =4. (e)
Subconfluent C3H10T1/2 pre-adipocytes were transfected with epitope-
taggedWTormutant forms of seipin, fixed and immunostained for seipin
using anti-FLAG antibody or with anti-calnexin antibody to reveal the
ER. Individual images are shown in greyscale, and merged images show
overlay of FLAG–seipin (green) and calnexin (red). Scale bars, 10 μm
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the failure of adipocyte development in cells expressing the
T78A, L91P and A212P mutant forms of seipin.
L91P and A212P forms of seipin display altered complex
formation The yeast orthologue of seipin, Fld1p, has been
reported to form a homo-oligomer of nine subunits in a
circular arrangement [7]. Moreover, analysis of a mutant form
of Fld1p carrying the single amino acid substitution G228P,
which mimics A212P in the human protein, suggested that
this mutation abrogated the ability of seipin to form this
oligomeric structure. To date, no studies have examined wheth-
er human seipin also forms high-order oligomers or whether
pathogenic point mutations affect homo-oligomerisation. To
study the architecture of human seipin, we selected AFM.
AFM is a scanning probe technique that provides nanometre-
scale resolution without the requirement for extensive sample
preparation [26]. FLAG-tagged wild-type seipin and the T78A,
A212P and L91P mutants were immunopurified and the iso-
lated protein was adsorbed to a mica substrate and imaged
using tapping-mode AFM in air. Figure 4a–d shows represen-
tative low-magnification images of the four seipin constructs.
Wild-type seipin (Fig. 4a) and the T78A mutant (Fig. 4b)
appeared as large particles of uniform size. In contrast, the
A212P mutant (Fig. 4c) and the L91P mutant (Fig. 4d)
appeared as noticeably smaller and less homogenous particles.
Fig. 2 The pathogenic point mutations T78A, L91P and A212P do not
affect seipin protein expression, but L91P and A212P seipin partially
mislocalise to the nuclear envelope. (a) HEK293 cells were transfected
with empty vector (−), the long form of wild-type seipin with N-terminal
triple-FLAG and C-terminal Myc tags (WT) or with identically tagged
T78A, L91P or A212P forms. Lysates were separated by SDS-PAGE and
immunoblotted for FLAG (α-FLAG) and calnexin (α-Calnexin). (b)
C3H10T1/2 cells were transfected with empty vector (−) or with epi-
tope-tagged WT or mutant forms of seipin as in (a ). Lysates were
separated by SDS-PAGE and immunoblotted for FLAG and calnexin.
In (a) and (b ) blots are representative of at least three independent
experiments. (c) Quantitative analysis of WT, T78A, L91P or A212P
forms of seipin protein in C3H10T1/2 cells. FLAG–seipin bands from
replicated blots as shown in (b) were normalised to calnexin expression
in the same samples and expressed as means ± SEM, n =3. *p <0.05 vs
WT. (d) C3H10T1/2 cells were transfected with empty vector (m) or with
epitope-tagged WT or mutant forms of seipin as in (a). Cells were
induced to differentiate for 2 days and expression of mRNA encoding
transfected human seipin (hBSCL2) was determined by real-time PCR.
Data are normalised to cyclophilin A and expressed as means ± SEM,
n =4. (e) Subconfluent C3H10T1/2 pre-adipocytes were transfected with
epitope-tagged WT or mutant forms of seipin and were fixed and immu-
nostained for seipin using anti-Myc antibody or with anti-calnexin anti-
body to reveal the ER. Individual images are shown in greyscale and
merged images show overlay of Myc–seipin (green) and calnexin (red).
Scale bars, 10 μm
Fig. 3 The pathogenic point mutations T78A, L91P and A212P do not
affect the capacity of seipin to bind the PA phosphatase lipin 1. (a)
HEK293 cells were transfected with empty vector (−), FLAG-tagged
long form of wild-type seipin (WT) or with identically tagged T78A,
L91P, A212P forms of seipin in the absence or presence of lipin 1β. Cell
lysates or anti-FLAG immunoprecipitates were immunoblotted for seipin
using anti (α)-FLAG antibodies or lipin 1β using and anti-lipin 1 anti-
bodies, as indicated. Lysates were also probed for calnexin as a loading
control. (b) The binding of lipin 1β to WTor mutant forms of seipin was
quantified in replicate immunoblots (n =3), normalised to expression
levels and expressed as a fold of that observed with wild-type seipin.
Data shown are means ± SEM
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The galleries of zoomed images of particles shown in Fig. 4e–h
confirm the difference in size between the two pairs of con-
structs; that is, wild-type (Fig. 4e) and T78A (Fig. 4f) vs A212P
(Fig. 4g) and L91P (Fig. 4h). Frequency distributions of vol-
umes of the particles, calculated using Equation 1, had peaks at
2,394±36 (mean ± SEM) nm3 (n =100) for wild-type seipin
(Fig. 4i), 2,396±22 nm3 (n =100) for the T78A mutant
(Fig. 4j), 753±20 nm3 (n =100) for the A212P mutant
(Fig. 4k) and 807±33 nm3 (n =100) for the L91P mutant
(Fig. 4l).
When isolated from transfected tsA 201 cells, the epitope-
tagged wild-type seipin and the T78A, A212P and L91P
mutants all migrated on polyacrylamide gels at an apparent
molecular mass of 80 kDa (data not shown). According to
Equation 2, the expected molecular volume for a protein of
this size is 152 nm3. It has been shown previously that after
solubilisation in Triton X-100, as here, the apparent molecular
mass of the seipin complex increases by about 28% because of
the presence of bound detergent; this would increase the
expected monomer size to 194 nm3. Dividing the observed
molecular volume (2,394 nm3 for wild-type seipin) by
194 nm3 gives a value of ∼12, suggesting that wild-type seipin
assembles as a dodecamer. According to this analysis, the
T78A mutant would also be dodecameric, whereas the
A212P and L91P mutants are on average about one-third of
this size.
Wild-type seipin and T78A seipin form ordered dodecamers It
is well known that measurement of the molecular volumes of
proteins by AFM is complicated by factors such as the con-
volution introduced by the geometry of the scanning tip.
Hence, the measured volume is not by itself a reliable indica-
tor of the stoichiometry of the seipin complex. To conclusively
establish the stoichiometry of the wild-type and T78A seipin
complexes, they were imaged either after incubation with
anti-Myc antibodies, which should decorate the C-terminal
Myc epitope tag present on each subunit, or anti-HA or
anti-V5 antibodies as negative controls. Representative low-
magnification AFM images of wild-type seipin are shown in
Fig. 5a. In the absence of antibodies, the large particles previ-
ously shown in Fig. 4a were again seen (Fig. 5a). After
incubation with anti-Myc antibodies, the large particles
became decorated by multiple smaller particles (antibodies,
indicated by arrows) and took on a rosette-like appearance
(Fig. 5a). Many unbound antibodies were also seen on the
mica substrate. In contrast, after incubation with anti-HA anti-
bodies, there was very little binding of antibodies to the seipin
complexes (Fig. 5a). Quantification of antibody binding
revealed that 88% of the seipin complexes were decorated by
anti-Myc antibodies (usually multiply), whereas only 18% of
the complexes were decorated by anti-HA antibodies (usually
singly). A similar antibody decoration profile was seen with
the T78A seipin mutant (Fig. 5b). In this case 83% of the seipin
particles were decorated by anti-Myc antibodies, compared
with 21%with anti-V5 antibodies. Galleries of zoomed images
of antibody-decorated wild-type and T78A mutant seipin
complexes are shown in Fig. 5c and Fig. 5d, respectively.
We measured the angles between the anti-Myc antibodies
bound to the seipin complexes. This was done by joining the
highest point on the central particle (the seipin complex) to the
highest points on the peripheral particles (the antibodies) by
lines and then determining the angle between the two lines. A
frequency distribution of the angles between pairs of antibod-
ies bound to wild-type seipin had several peaks at multiples of
30° (Fig. 5e), consistent with the above suggestion, based on
molecular volume, that seipin assembles as a dodecamer. The
observed angle profile also suggests that the dodecamer has a
circular structure, which becomes decorated around the rim.
Fig. 4 Wild-type human seipin and T78A mutant seipin form high-
molecular-mass oligomers, while L91P seipin and A212P seipin are
unable to do so. (a–d) tsA 201 cells were transfected with the long form
of wild-type seipin with an N-terminal triple-FLAG tag and a C-terminal
Myc tag (a) or with the T78A (b), A212P (c) or L91P (d) mutant forms
of this protein. Isolated proteins were subjected to AFM imaging. Scale
bar, 200 nm; shade-height scale, 0–5 nm. (e–h) Galleries of zoomed
images of wild-type seipin (e) and the T78A (f), A212P (g) and L91P (h)
mutants. Scale bar, 20 nm; shade-height scale, 0–5 nm. (i–l) Frequency
distributions of molecular volumes of wild-type (i), T78A (j), A212P (k)
and L91P (l) seipin. The curves indicate the fitted Gaussian functions
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The repeating 30° separation between bound antibodies ex-
cludes a spherical subunit arrangement, which would give a
much more confused angle distribution. The same profile of
angle peaks was seen with the T78A seipin mutant (Fig. 5f),
indicating that it too assembles as a circular dodecamer.
Discussion
Pathogenic mutations in BSCL2 , causing severe generalised
lipodystrophy, were first reported by Magre and colleagues in
2001 [2]. However, information about the molecular functions
of its protein product seipin is only now emerging. In the
absence of information regarding its defined functions or
structure it has been difficult to uncover how pathogenic
mutations in the protein might disrupt the normal function of
seipin and cause disease.
We have confirmed that the R275X mutant of seipin ap-
pears to be very unstable, in this case using the long translation
of the protein bearing the mutation as a single base pair change
in the full coding sequence. Once again our data imply that
individuals carrying this mutation will be unable to generate
even a truncated seipin protein. Our data indicate that this
dramatic instability does not occur with any of the other
premature stop mutations or missense mutations examined
in this study. However, we did observe modest decreases in
the expression of the L91P and A212P seipin and acknowl-
edge that such subtle alterations in the stability of these or
other mutant seipin proteins might yet prove relevant in vivo.
All of the premature stop mutants of seipin examined localise
appropriately to the ER membrane in pre-adipocytes. Overall,
the current data suggest that the failure to bind lipin 1 appro-
priately, which we reported in our previous study, offers a
plausible pathogenic mechanism for these more stable trun-
cated forms of seipin [17]. In contrast, the missense point
mutations of seipin tested here all retain the capacity to bind
lipin 1, which we observed for wild-type seipin, suggesting
that in itself this is unlikely to explain the inability of these
mutants to support adipocyte development in vivo.
Our experiments using AFM reveal that human seipin
forms homo-oligomers reminiscent of those reported for the
yeast Fld1p. However, instead of the nine subunits seen with
the yeast seipin orthologue we find that the human protein
assembles into 12-subunit structures. Binns et al postulated
that yeast seipin might be structurally involved in the budding
or organisation of LDs at the ER [7]. Our work identifying the
interaction of seipin with lipin 1 and ongoing studies of other
seipin-interacting proteins suggest to us that this oligomeric
structure could also be essential for the correct juxtaposition of
seipin-associated proteins with each other and/or their sub-
strates. The failure of L91P and A212P seipin to oligomerise
evidently could affect either of these potential functions.
Hence, the failure to assemble appropriately appears likely
to represent a key pathogenic mechanism for L91P and
A212P seipin. Fei and colleagues recently demonstrated that
A212P seipin does not inhibit triacylglycerol accumulation in
oleate-loaded cells as efficiently as wild-type seipin [20]. They
also showed that wild-type seipin can co-precipitate other
seipin molecules including A212P seipin. These results are
consistent with our AFM data showing that human seipin
forms oligomers, although it is not clear whether these hybrid
complexes of wild-type and A212P seipin form dodecameric
structures as does the wild-type seipin alone. If so, this could
partly explain why heterozygous carriers of the A212P muta-
tion exhibit no discernible phenotype [2, 4]. A recent study
has also reported that A212P might act as a dominant negative
inhibitor of adipogenesis if overexpressed [27]. We speculate
Fig. 5 Both wild-type human seipin and T78A mutant seipin form
dodecamers. (a) AFM images of wild-type seipin either alone or after
incubation with anti-Myc or anti-HA antibodies. (b) AFM images of T78A
mutant seipin either alone or after incubation with either anti-Myc or anti-
V5 antibodies. Arrows indicate multiply decorated seipin complexes. Scale
bar, 100 nm; shade-height scale, 0–5 nm. (c , d) Gallery of zoomed images
showingmultiply decorated wild-type (c) or T78Amutant seipin (d). Scale
bar, 20 nm; shade-height scale, 0–5 nm. (e, f) Frequency distributions of
angles between pairs of antibodies bound to either wild-type (e) or T78A
mutant seipin (f). The curves indicate the fitted Gaussian functions
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that this could result from the failure to appropriately form
dodecamers when the stoichiometry is shifted to a higher ratio
of A212P to wild-type seipin. Evidently AFM offers a means
to investigate these possibilities further.
It has been suggested that the G228P mutant of yeast seipin
is unstable and that this may result from altered oligomerisation
[7]. In our study A212P seipin was expressed robustly although
we did observe modestly reduced expression of this and the
L91P mutant compared with wild-type seipin [13]. In addition
L91P seipin displayed altered mobility on SDS-PAGE. While
the reason for this is not clear this could reflect altered glyco-
sylation given the proximity to the known glycosylation site at
N88. Overall the data imply that altered oligomerisation could
be associated with modestly reduced stability and partially
altered localisation for both these mutants.
Finally, it is notable that the T78A seipin protein was
indistinguishable from wild-type in any of the aspects of
seipin stability, structure or function tested. This observation
implies that at least one further molecular mechanism exists
that accounts for the inability of individuals carrying this
mutation to develop functional adipose tissue. Further infor-
mation regarding the molecular functions of seipin, perhaps
including its interaction with additional binding proteins, may
shed light on the specific defect caused by the T78Amutation.
Overall, the results of this study suggest at least four
potential mechanisms by which different pathogenic muta-
tions in seipinmay lead to a loss of functional protein resulting
in failed adipogenesis and ultimately lipodystrophy in affected
individuals: (1) decreased protein stability and consequent
lack of functional protein (R275X); (2) reduced ability to bind
lipin 1 and target this key adipogenic enzyme appropriately to
the ER (E113X, R138X, Q391X); (3) failure to oligomerise
appropriately and localise exclusively to the ER membrane
(L91P and A212P); (4) an as-yet undetermined additional
mechanism (T78A). The existence of multiple molecular
mechanisms underlying the development of disease due to
mutations in only one protein is not unusual. In this regard we
note the parallel with partial lipodystrophies caused by muta-
tions in PPARγ, where different mutations can render PPARγ
unable to bind DNA appropriately, to become activated by
ligands and to associate with co-activators or dissociate from
co-repressors [28].
We believe that this study represents the most comprehen-
sive analysis of pathogenic mutations in seipin performed so
far and reveals significant new information regarding both the
oligomeric structure of wild-type human seipin and the poten-
tial molecular mechanisms by which different pathogenic
mutations may cause severe lipodystrophy.
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